We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-4.34%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.17B
AUM Growth
+$167M
Cap. Flow
+$256M
Cap. Flow %
21.92%
Top 10 Hldgs %
3.75%
Holding
2,064
New
608
Increased
491
Reduced
336
Closed
627

Top Buys

Rank Stock Value
1
RVLV icon
Revolve Group
RVLV
+$4.47M
2
AES icon
AES
AES
+$4.1M
3
DG icon
Dollar General
DG
+$4.08M
4
MOMO
Hello Group
MOMO
+$4.03M
5
STZ icon
Constellation Brands
STZ
+$3.97M

Top Sells

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$4.49M
2
CPA icon
Copa Holdings
CPA
+$3.78M
3
IDXX icon
Idexx Laboratories
IDXX
+$2.94M
4
CDLX icon
Cardlytics
CDLX
+$2.79M
5
SONO icon
Sonos
SONO
+$2.61M

Sector Composition

Rank Sector Weight
1 Healthcare 14.28%
2 Consumer Discretionary 13.84%
3 Technology 13.57%
4 Financials 11.67%
5 Industrials 11.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAYO icon
1376
Payoneer
PAYO
$2.41B
$110K 0.01%
+17,893
New +$101K
ADCT icon
1377
ADC Therapeutics
ADCT
$144M
$109K 0.01%
121,897
+13,012
+12% +$17.3K
EIGR
1378
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$109K 0.01%
11,862
+2,339
+25% +$47K
KRNY icon
1379
Kearny Financial
KRNY
$599M
$105K 0.01%
15,096
-68,866
-82% -$522K
VINP icon
1380
Vinci Compass Investments Ltd
VINP
$660M
$105K 0.01%
+10,308
New +$104K
ASPN icon
1381
Aspen Aerogels
ASPN
$518M
$104K 0.01%
+12,061
New +$85.7K
IMPP icon
1382
Imperial Petroleum
IMPP
$208M
$104K 0.01%
+65,582
New +$135K
DSGN icon
1383
Design Therapeutics
DSGN
$876M
$103K 0.01%
43,581
-194,619
-82% -$908K
ALDX icon
1384
Aldeyra Therapeutics
ALDX
$93.5M
$102K 0.01%
15,264
-64,443
-81% -$478K
ORC
1385
Orchid Island Capital
ORC
$1.31B
$102K 0.01%
+11,956
New +$117K
EOLS icon
1386
Evolus
EOLS
$501M
$101K 0.01%
11,026
-87,352
-89% -$783K
KURA icon
1387
Kura Oncology
KURA
$850M
$101K 0.01%
11,039
-98,156
-90% -$997K
COGT icon
1388
Cogent Biosciences
COGT
$7.24B
$100K 0.01%
+10,281
New +$122K
THRX
1389
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$98K 0.01%
+36,587
New +$143K
AMRX icon
1390
Amneal Pharmaceuticals
AMRX
$5.79B
$97K 0.01%
22,986
-91,265
-80% -$340K
KGC icon
1391
Kinross Gold
KGC
$32.8B
$96K 0.01%
+21,145
New +$104K
PRQR icon
1392
ProQR Therapeutics
PRQR
$265M
$96K 0.01%
74,084
+30,248
+69% +$47.6K
PNT
1393
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$93K 0.01%
13,987
-31,297
-69% -$260K
VRCA icon
1394
Verrica Pharmaceuticals
VRCA
$87.3M
$90K 0.01%
2,321
-1,496
-39% -$76K
NVAX icon
1395
Novavax
NVAX
$1.31B
$87K 0.01%
+12,024
New +$96.1K
FCEL icon
1396
FuelCell Energy
FCEL
$1.63B
$86K 0.01%
+2,236
New +$117K
PACW
1397
DELISTED
PacWest Bancorp
PACW
$82K 0.01%
10,351
-55,711
-84% -$465K
PMVP icon
1398
PMV Pharmaceuticals
PMVP
$63.5M
$80K 0.01%
13,045
-101,559
-89% -$698K
RPT
1399
Rithm Property Trust
RPT
$93.7M
$76K 0.01%
1,956
-14,486
-88% -$586K
PFSW
1400
DELISTED
PFSweb, Inc.
PFSW
$76K 0.01%
10,258
-21,692
-68% -$113K
54 55
56
57 58

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2023 Portfolio in Review

As of Q3 2023, GSA Capital Partners held 2,064 positions worth $1.17B, up 17% from $1B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.

GSA Capital Partners deployed $256M of net new capital in Q3 2023, opening 608 new positions and adding to 491 existing holdings. Its largest new stake was Revolve Group: 280,700 shares worth $3.82M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Cardlytics, an estimated $2.79M trimmed.

  • GSA Capital Partners's largest Q3 2023 buy was Revolve Group: 280,700 shares worth $3.82M.
  • GSA Capital Partners added most to Hello Group in Q3 2023, an estimated $4.03M increase.
  • GSA Capital Partners's biggest Q3 2023 reduction was Cardlytics, cutting an estimated $2.79M.
  • GSA Capital Partners fully exited e.l.f. Beauty in Q3 2023, selling an estimated $4.49M.
  • GSA Capital Partners's ten largest holdings make up 3.8% of its $1.17B portfolio in Q3 2023.
  • GSA Capital Partners opened 608 new positions and closed 627 in Q3 2023.
  • GSA Capital Partners's portfolio value rose 17% quarter-over-quarter to $1.17B.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.